Inactive Instrument

Vifor Pharma AG Stock price SIX SWISS EXCHANGE - BLUE CHIPS SEGMENT

Equities

VIFN

CH0364749348

Pharmaceuticals

Dynamic Chart
Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its portfolio of renal pharmaceuticals includes products for anaemia management, such as Mircera, mineral and bone management, such as Velphoro, Rayaldee and Osvaren, and cardio-renal management, such as patiromer (in the United States sold under the brand Veltassa). The Company also conducts research in the area of infectious and rare diseases, partnering with other biopharmaceutical companies. The Company has production sites in Switzerland and Portugal as well as a network of affiliates and partners around the world.
More about the company
  1. Stock
  2. Equities
  3. Stock Vifor Pharma
  4. Stock Vifor Pharma AG - SIX SWISS EXCHANGE - BLUE CHIPS SEGMENT